How is Chronic myelogenous leukemia (CML) diagnosed?

Chronic myelogenous leukemia (CML) is primarily diagnosed through blood tests that reveal elevated white blood cell counts, followed by confirmation via genetic testing to identify the Philadelphia chromosome (BCR-ABL1 fusion gene). Because symptoms can be vague or absent in early stages, Chronic myelogenous leukemia (CML) is frequently discovered incidentally during routine medical exams.

How is Chronic myelogenous leukemia (CML) diagnosed?

The diagnostic process for Chronic myelogenous leukemia (CML) usually begins with a Complete Blood Count (CBC), which often shows an abnormally high white blood cell count. If findings are suspicious, a hematologist-oncologist will perform a bone marrow aspiration and biopsy. The definitive diagnostic criteria involve identifying the BCR-ABL1 genetic mutation, which acts as the hallmark of Chronic myelogenous leukemia (CML).

What tests confirm the diagnosis?

To confirm Chronic myelogenous leukemia (CML), clinicians utilize several specialized laboratory techniques:

• Cytogenetic analysis (Karyotyping): Checks for the presence of the Philadelphia chromosome (a translocation between chromosomes 9 and 22).


• Fluorescence In Situ Hybridization (FISH): A rapid test to detect the BCR-ABL1 gene fusion.


• Quantitative Polymerase Chain Reaction (qPCR): Measures the exact amount of BCR-ABL1 transcript, which is crucial for monitoring treatment response.

Why is the diagnostic journey often difficult?

Many of the 287 members of our DiseaseMaps.org community have expressed frustration regarding the "diagnostic odyssey" associated with rare conditions. Because Chronic myelogenous leukemia (CML) may present with non-specific symptoms like fatigue or night sweats, it is often initially mistaken for common infections or other hematologic disorders, such as primary myelofibrosis or other myeloproliferative neoplasms. Seeking a hematologist—a blood specialist—is vital, as general practitioners may not be familiar with the nuances of CML testing.

Next steps

• Consult a hematologist-oncologist immediately if your blood work shows unexplained, persistent elevations in white blood cells.


• Request a bone marrow biopsy and genetic testing for the BCR-ABL1 fusion gene.


• Join the DiseaseMaps.org community to connect with others who have navigated the Chronic myelogenous leukemia (CML) diagnostic process.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• National Cancer Institute (NCI) - Chronic Myelogenous Leukemia Treatment


• Leukemia & Lymphoma Society (LLS)